Carlyle Group (CG) Eyes Buyout of Baxter's Kidney Care Unit

Per the source, the companies started exclusive negotiations in late June and an agreement could be announced as soon as this week. However, there is a chance that the discussions will fail or another bidder may emerge. Baxter plans to spin off Vantive in the second half of 2024, intending to separate its acute therapies and renal care business. Also, the company's global presence and efforts to expand business are expected to continue aiding asset under management (AUM) growth and boost its investment perf ...